DK0010272201
Impact Score
Genmab A/S is a biotechnology company specializing in the development of differentiated antibody therapeutics for the treatment of cancer.
Impact Score
Metric | Value | Unit | Year | PDF Name | PDF Page | |
---|---|---|---|---|---|---|
CEO-to-Employee Pay Ratio | ||||||
Jan G. J. van de Winkel | 2023 | 0001558370-24-001137.pdf | 87 | |||
44,3 | DKK million | 2023 | Genmab 2023 Annual Report.pdf | 111 | ||
3 548 | DKK million | 2023 | Genmab 2023 Annual Report.pdf | 87 | ||
2 011 | employees | 2023 | Genmab 2023 Annual Report.pdf | 10 | ||
Employee turnover rate | ||||||
6 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 | ||
Glass Ceiling | ||||||
52 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 | ||
58 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 | ||
Greenhouse Gas Emissions | ||||||
317 | tCO2e | 2023 | Corporate Responsibility Report 2023.pdf | 37 | ||
238 | tCO2e | 2023 | Corporate Responsibility Report 2023.pdf | 37 | ||
2 011 | employees | 2023 | Genmab 2023 Annual Report.pdf | 10 | ||
Harassment and Discrimination at the Workplace | ||||||
Yes | 2023 | Corporate Responsibility Report 2023.pdf | 32 | |||
Yes | 2023 | Human Rights Commitment FINAL.pdf | 1 | |||
Yes | 2023 | Corporate Responsibility Report 2023.pdf | 32 | |||
Yes | 2023 | Human Rights Commitment FINAL.pdf | 1 | |||
Renewable Energy | ||||||
83 | % | 2023 | Corporate Responsibility Report 2023.pdf | 37 | ||
Union Formation and Collective Bargaining Power | ||||||
0 | % | 2023 | 0001558370-24-001137.pdf | 96 | ||
Women on the Board | ||||||
9 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
0 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
2 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
2 | members | 2023 | Genmab 2023 Annual Report.pdf | 131 | ||
Women in Management | ||||||
52 | % | 2023 | Genmab 2023 Annual Report.pdf | 50 |